Is Translational Development Acquisition Corp. (TDAC) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | Excluded — Shell Companies | ✗ NOT HALAL | |||
| DJIM | Excluded — Shell Companies | ✗ NOT HALAL | |||
| MSCI | Excluded — Shell Companies | ✗ NOT HALAL | |||
| S&P | Excluded — Shell Companies | ✗ NOT HALAL | |||
| FTSE | Excluded — Shell Companies | ✗ NOT HALAL | |||
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -0.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$851,446 |
| Free Cash Flow | -$851,446 |
| Current Ratio | 0.2 |
| Total Assets | $175M |
Price & Trading
| Last Close | $10.57 |
| 50-Day MA | $10.53 |
| 200-Day MA | $10.41 |
| Avg Volume | 12K |
|
52-Week Range
$10.07
| |
About Translational Development Acquisition Corp. (TDAC)
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Related Halal Stocks in Financial Services
Frequently Asked Questions
Is Translational Development Acquisition Corp. (TDAC) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Translational Development Acquisition Corp. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Translational Development Acquisition Corp.'s debt ratio?
Translational Development Acquisition Corp.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%.
What are Translational Development Acquisition Corp.'s key financial metrics?
Translational Development Acquisition Corp. has a market capitalization of $232M, trailing P/E ratio of 48.1.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.